Lack of ataxia telangiectasia mutated kinase induces structural and functional changes in the heart: Role in β-adrenergic receptor-stimulated apoptosis

Experimental Physiology

Volumn 97, Issue 4, 2012, Pages 506-515

  Foster, Cerrone R ^a   Zha, Qinqin ^a   Daniel, Laura L ^a   Singh, Mahipal ^a   Singh, Krishna ^a,b  

^a East Tennessee State University   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE A; GELATINASE B; GLYCOGEN SYNTHASE KINASE 3BETA; ISOPRENALINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE;

A WAVE; ANIMAL CELL; APOPTOSIS; ARTICLE; BETA ADRENERGIC STIMULATION; BODY WEIGHT; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ENZYME ACTIVITY; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART WEIGHT; M MODE ECHOCARDIOGRAPHY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PULSE WAVE;

EID: 84859650507     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1111/j.1469-445X.2011.01034.x     Document Type: Article

References (38)

1. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D & Wynshaw-Boris A (1996). Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159-171.
2. Bergman MR, Teerlink JR, Mahimkar R, Li L, Zhu BQ, Nguyen A, Dahi S, Karliner JS & Lovett DH (2007). Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction. Am J Physiol Heart Circ Physiol 292, H1847-H1860.
3. Boehrs JK, He J, Halaby MJ & Yang DQ (2007). Constitutive expression and cytoplasmic compartmentalization of ATM protein in differentiated human neuron-like SH-SY5Y cells. J Neurochem 100, 337-345.
4. Chien KR, Knowlton KU, Zhu H & Chien S (1991). Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 5, 3037-3046.
5. Collins KA, Korcarz CE, Shroff SG, Bednarz JE, Fentzke RC, Lin H, Leiden JM & Lang RM (2001). Accuracy of echocardiographic estimates of left ventricular mass in mice. Am J Physiol Heart Circ Physiol 280, H1954-H1962.
6. Foster CR, Singh M, Subramanian V & Singh K (2011). Ataxia telangiectasia mutated kinase plays a protective role in β-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Mol Cell Biochem 353, 13-22.
7. Fowler MB, Laser JA, Hopkins GL, Minobe W & Bristow MR (1986). Assessment of the β-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74, 1290-1302.
8. Gardin JM, Adams DB, Douglas PS, Feigenbaum H, Forst DH, Fraser AG, Grayburn PA, Katz AS, Keller AM, Kerber RE, Khandheria BK, Klein AL, Lang RM, Pierard LA, Quinones MA & Schnittger I (2002). Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr 15, 275-290.
9. Golding SE, Rosenberg E, Valerie N, Hussaini I, Frigerio M, Cockcroft XF, Chong WY, Hummersone M, Rigoreau L, Menear KA, O'Connor MJ, Povirk LF, van Meter T & Valerie K (2009). Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion. Mol Cancer Ther 8, 2894-2902.
10. Hardt SE & Sadoshima J (2002). Glycogen synthase kinase-3β: a novel regulator of cardiac hypertrophy and development. Circ Res 90, 1055-1063.
11. Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, Kubota T, Imanaka-Yoshida K, Itoh T & Takeshita A (2003). Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 285, H1229-H1235.
12. Huynh K, McMullen, JR, Julius TL, Tan JW, Love JE, Cemerlang N, Kiriazis H, Du XJ & Ritchie RH (2010). Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes 59, 1512-1520.
13. Kajstura J, Bolli R, Sonnenblick EH, Anversa P & Leri A (2006). Cause of death: suicide. J Mol Cell Cardiol 40, 425-437.
14. Khanna KK, Lavin MF, Jackson SP & Mulhern TD (2001). ATM, a central controller of cellular responses to DNA damage. Cell Death Differ 8, 1052-1065.
15. Krishnamurthy P, Subramanian V, Singh M & Singh K (2007). β1 integrins modulate β-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Hypertension 49, 865-872.
16. Kwon O, Kim KA, He L, Kim SO, Kim MS, Cha EY, Yoon BD, Sok DE, Jung M, Ahn JS & Kim BY (2008). Ionizing radiation can induce GSK-3β phosphorylation and NF-κB transcriptional transactivation in ATM-deficient fibroblasts. Cell Signal 20, 602-612.
17. Lavin MF, Khanna KK, Beamish H, Spring K, Watters D & Shiloh Y (1995). Relationship of the ataxia-telangiectasia protein ATM to phosphoinositide 3-kinase. Trends Biochem Sci 20, 382-383.
18. Lee SA, Dritschilo A & Jung M (1998). Impaired ionizing radiation-induced activation of a nuclear signal essential for phosphorylation of c-Jun by dually phosphorylated c-Jun amino-terminal kinases in ataxia telangiectasia fibroblasts. J Biol Chem 273, 32889-32894.
19. Meulmeester E & Jochemsen AG (2008). p53: a guide to apoptosis. Curr Cancer Drug Targets 8, 87-97.
20. Miyamoto S, Murphy AN & Brown JH (2009). Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue. J Bioenerg Biomembr 41, 169-180.
21. Mujumdar VS, Smiley LM & Tyagi SC (2001). Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Int J Cardiol 79, 277-286.
22. Nadal-Ginard B, Kajstura J, Leri A & Anversa P (2003). Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92, 139-150.
23. Nearchou NS, Karatzis EN, Lolaka MD, Marnelos PG, Tsitsirikos MD, Moutiris JA, Mavrommatis PP & Tsakiris AK (2006). Mitral A-wave deceleration time. A marker of left ventricular diastolic dysfunction following acute myocardial infarction? Int J Cardiol 109, 129-131.
24. Quinones MA, Gaasch WH, Cole JS & Alexander JK (1975). Echocardiographic determination of left ventricular stress-velocity relations. Circulation 51, 689-700.
25. 2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 92, 136-138.
26. Samarakoon R, Goppelt-Struebe M & Higgins PJ (2010). Linking cell structure to gene regulation: signaling events and expression controls on the model genes PAI-1 and CTGF. Cell Signal 22, 1413-1419.
27. Shiloh Y (2001). ATM and ATR: networking cellular responses to DNA damage. Curr Opin Genet Dev 11, 71-77.
28. Singh K, Communal C, Sawyer DB & Colucci WS (2000). Adrenergic regulation of myocardial apoptosis. Cardiovasc Res 45, 713-719.
29. Singh K, Xiao L, Remondino A, Sawyer DB & Colucci WS (2001). Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 189, 257-265.
30. Spinale FG (2002). Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 90, 520-530.
31. Su Y & Swift M (2000). Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med 133, 770-778.
32. Viniegra JG, Martínez N, Modirassari P, Losa JH, Parada CC, Lobo VJ, Luquero CI, Alvarez-Vallina L, Ramon y Cajal S, Rojas JM & Sánchez-Prieto R (2005). Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J Biol Chem 280, 4029-4036.
33. Wang GY, Bergman MR, Nguyen AP, Turcato S, Swigart PM, Rodrigo MC, Simpson PC, Karliner JS, Lovett DH & Baker AJ (2006). Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility. Cardiovasc Res 69, 688-696.
34. Watters D, Kedar P, Spring K, Bjorkman J, Chen P, Gatei M, Birrell G, Garrone B, Srinivasa P, Crane DI & Lavin MF (1999). Localization of a portion of extranuclear ATM to peroxisomes. J Biol Chem 274, 34277-34282.
35. Weber KT (2004). From inflammation to fibrosis: a stiff stretch of highway. Hypertension 43, 716-719.
36. Weber KT, Sun Y, Tyagi SC & Cleutjens JP (1994). Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26, 279-292.
37. Yan M, Kuang X, Qiang W, Shen J, Claypool K, Lynn WS & Wong PK (2002). Prevention of thymic lymphoma development in Atm-/- mice by dexamethasone. Cancer Res 62, 5153-5157.
38. Yang DQ & Kastan MB (2000). Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol 2, 893-898.